EBS News and Press, Emergent Biosolutions Inc. From 05/01/20

Image source: The Motley Fool. Emergent BioSolutions Inc   (NYSE: EBS) Q1 2020 Earnings Call Apr 30, 2020 , 5:00 p.m. ET Operator Continue reading

Emergent Biosolutions (NYSE: EBS ): Q1 Non-GAAP EPS of $0.01; GAAP EPS of -$0.24 beats by $0.10 . More news on: Emergent BioSolutions Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

Reaffirms full year 2020 financial forecast Executes multi-faceted response to COVID-19 drawing upon longstanding investments in capabilities to address public health threats, as well as expertise in vaccines, therapeutics, and contract development and manufacturing GAITHERSBURG, Md.,...

Shares of drug manufacturer Catalent (NYSE: CTLT) were up by 10% at 2 p.m. Wednesday after the company announced it had signed an agreement with the Janssen Pharmaceuticals subsidiary of Johnson & Johnson (NYSE: JNJ) to manufacture a COVID-19 vaccine. The agreement includes joint inv...

When it comes to hot coronavirus stocks, investors have likely heard a lot about the many potential vaccines and other treatments currently being developed. However, there is one company working in the COVID-19 vaccine market that hasn't gotten much attention in comparison with some of its peers...

It could get worse. I know, those are four words that you don't want to hear right now. And, unfortunately, I'm not referring to the state of affairs relating to the novel coronavirus or the COVID-19 disease that it causes -- although the head of the Centers for Disease Control and Prevention (...

As the coronavirus pandemic continues, investors from every part of the spectrum are looking for safe, stable companies to rely on -- and a nice dividend doesn't hurt. Here are three great healthcare stocks whose dividends are the cherry on top of a great operation.  I love Johnson & ...

Mylan Gets European Union Nod for Upjohn Merger Mylan NV ( MYL ) reported that the European Union has given its approval to the company's merger with Pfizer’s ( PFE ) Upjohn. However, this antitrust clearance comes with certain caveats such as the offloading of certain assets. The E...

Shares of Emergent BioSolutions (NYSE: EBS) were up by 8% as of 12:08 p.m. EDT on Friday. The market is likely responding to the news that Emergent BioSolutions signed a $135 million contract with Johnson & Johnson (NYSE: JNJ) . Per the terms of the agreement between the two entitie...

Johnson & Johnson (NYSE: JNJ ) says it will work with Emergent BioSolutions (NYSE: EBS ) to produce more than a billion doses of a COVID-19 vaccine candidate, as it seeks to scale up global manufacturing of its potential treatment. More news on: Johnson & Johnson, Emergent BioSol...